COMP <GO>
PRGO vs UNH // PIOTROSKI F-SCORE QUALITY
Perrigo Company plc (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: PRGO 2
— UNH 9
▲ PIOTROSKI F-SCORE QUALITY LEADER: UNH
LAST: $15.75 (-0.19%) • MKT CAP: $2.19B
piotroski-score
5/9
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRGO VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PRGO | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.10% | 88.31% | -53.21 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -13.60% | 12.38% | -25.98 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 6.58% | 6.25% | +0.33 | PRGO | /fcf-yield <GO> |
| Operating Margin | -26.40% | 5.32% | -31.72 | UNH | /operating-margins <GO> |
| Net Profit Margin | -33.50% | 3.53% | -37.03 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | -2.80% | 3.33% | -6.13 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 7.22% | 2.29% | +4.93 | PRGO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 3.09 | -2.89 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 5/9 | 7/9 | -2.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.3 | 55.1 | -0.80 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.19B | $359.43B | -$357.25B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PRGO REV | UNH REV | PRGO GROSS % | UNH GROSS % | PRGO FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.25B | $447.57B | 35.1% | 88.7% | $145.1M | $16.07B |
| FY 2024 | $4.37B | $400.28B | 35.3% | 88.3% | $244.6M | $20.70B |
| FY 2023 | $4.66B | $371.62B | — | 89.6% | $405.5M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRGO // BETA —
UNH // BETA 0.33